>

WEBINARS

RSS
>

MEETINGS / EVENTS

RSS
>

FDA MEDWATCH ALERTS

RSS

May 14, 2013

Zolpidem Containing Products: Drug Safety Communication - FDA Requires Lower Recommended Doses

Summary:

Zolpidem Containing Products Drug Safety Communication

May 09, 2013

The Compounding Shop: FDA News Release - Lack of Sterility Assurance of Drug Products

Summary:

The Compounding Shop FDA News Release Lack of Sterility

May 08, 2013

Maquet SERVO-i Ventilator Battery Module: Class 1 Recall - Battery Run Time Shorter Than Expected

Summary:

Maquet SERVOi Ventilator Battery Module Class 1 Recall Battery Run Time Shorter Than Expected

>

ASA FEATURED PRODUCT

Add this product to your shopping cart

Anesthesiology Continuing Education (ACE) Program

SKU: 30702-13CE

... Read more »

Single Copies, Member Price: $360

Office of General Counsel

 

The Office of General Counsel (OGC) is responsible for the legal affairs of ASA.  The OGC represents the Society on a broad range of legal issues, including but not limited to:

  • Administration of the Expert Witness Testimony Review Program
  • Review and negotiation of all Society contracts
  • Intellectual Property matters
  • Antitrust concerns
  • Tax law matters
  • Nonprofit corporate legal issues
  • Governance

This page includes links to important information and resources regarding the Society’s expert witness and intellectual property programs. For further information or questions regarding the OGC, please contact the Washington, D.C. office at (202) 289-2222.

 

ASA Antitrust Statement

ASA Copyright Policy 

License Information for CROSSWALK®, Reverse CROSSWALK, and Relative Value Guide®

Expert Witness Testimony Review Program